SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals (VNDA) is trending sharply following FDA approval of BYSANTI for bipolar I disorder and schizophrenia, fueling community excitement for substantial upside, a potential short squeeze, and speculation that the approval strengthens the case for future pipeline successes and a possible acquisition.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

Crowdstrike is trending amidst a sector-wide sell-off driven by concerns that Anthropic's new Claude Code Security AI tool could disrupt cybersecurity, though the community remains divided, with many asserting minimal overlap with CRWD's core offerings while others caution about its high valuation.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR Protocol is trending due to its robust cross-chain "Intents" technology enabling seamless interoperability with major ecosystems like Starknet on Solana, and its enhanced AI integrations including a partnership with NVIDIA. With a Grayscale Trust filing signaling institutional interest and a recent reduction in token inflation, the community views NEAR as a strategic long-term hold despite current market volatility.

JFrog Ltd. engages in the provision of an end-to-end, hybrid, universal development operations platform that powers and controls the software supply chain, which enables organizations to continuously and securely deliver software updates across any system. It operates through the following geographical segments: United States, Israel, India, and Rest of World. The firm is also involved in creating software delivered without friction from developer to device. The company was founded by Frederic Simon, Shlomi Ben Haim, and Yoav Landman in 2008 and is headquartered in Sunnyvale, CA.

JFrog Ltd

JFrog ($FROG) is trending after a substantial stock plunge, driven by market concerns that Anthropic's Claude Code Security could disrupt its DevSecOps business; however, community discussion is divided, with many viewing the sharp sell-off as an overreaction and a potential buying opportunity.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy (SWEAT CRYPTO) is trending as its community discusses the unique move-to-earn utility and staking potential, despite acknowledging its current low prices and significant year-over-year drops. Many investors are expressing long-term conviction, anticipating the token will "rise one day" and often linking its prospects to the NEAR ecosystem.

Santacruz Silver Mining Ltd. engages in the acquisition, exploration, and development of mineral properties. It operates through the following segments: Bolivar, Porco, Caballo Blanco Group, San Lucas Group, Zimapan, and Corporate and Other. The Bolivar segment focuses on mine and processing plants. The Porco segment is invovled in mine and processing plants. The Caballo Blanco Group segment includes the Tres Amigos, Colquechaquita mines and the Don Diego processing plant. The San Lucas Group segment refers to Reserva mine and San Lucas feed sourcing business. The Zimapan segment consists of mine and processing plant. The company was founded on January 24, 2011 and is headquartered in Vancouver, Canada.

Santacruz Silver Mining Ltd

Santacruz Silver Mining Ltd.

Santacruz Silver Mining Ltd. (SCZMF) is trending following its recent Nasdaq uplisting and strong operational performance, which has prompted a research firm to significantly raise its price target. The community is actively discussing the stock's perceived undervaluation and substantial profit potential, driven by a bullish outlook for silver prices and anticipation of increased institutional interest.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as community discussion focuses on its strategic exclusion from China's national drug list, aiming to preserve pricing power, while investors keenly await a pending U.S. Supreme Court decision on its patent infringement case. This coincides with anticipated positive financial results and ongoing speculation about a potential acquisition as the company positions for a turnaround.

Bombardier Cl B Sv

Bombardier is a key topic following strong financial reports, including exceeding guidance and securing new orders, as the community actively debates its market valuation and navigates the political noise around potential tariffs.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne is trending as the cybersecurity sector faces a sell-off driven by concerns about new AI-powered security tools, though the community largely dismisses these as irrelevant to advanced endpoint protection. Many investors highlight $S as an AI-native leader with strong fundamentals and no debt, viewing its current undervaluation as a significant buying opportunity or potential acquisition target.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy is attracting significant attention with cryptic teasers of a major business update, including its new "Indensity" battery architecture targeting data centers, generating intense debate among investors over potential large orders and a short squeeze versus ongoing concerns about valuation and earnings execution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$DYAI https://seekingalpha.com/pr/20401061-dyadic-applied-biosolutions-and-proliant-health-and-biologicals-announce-commercial-launch-of

Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered, animal-free proteins and enzymes for life science, food and nutrition, and bio-industrial uses, and Proliant Health& Biologicals, a leading global producer of albumin and other purified proteins for life science, nutrition, and diagnostic applications, today...

Seeking Alpha

Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin (2026-02-17)

StockTwits Web

Dyadic International Inc., DE

Coherus Biosciences Inc

Synchronoss Technologies Inc

Xtant Medical Holdings Inc

Cellectar Biosciences Inc

Creative Realities Inc

Algorhythm Holdings Inc.

Charlie

@Glopolon you&#39;ve been following this stock since Covid. How are you feeling with the company progress?

StockTwits for iOS

 you've been following this stock since Covid. How are you feeling with the company progress?

Beyond Meat Inc

Martin Cortez

@MartyCortez EU determined C1 was optimal way to make proteins.  US already wrongly pre-decided on mRNA.  C1 is the best platform there is.  Just a matter of time.  Glad they are generating revenue now.

 EU determined C1 was optimal way to make proteins.  US already wrongly pre-decided on mRNA.  C1 is the best platform there is.  Just a matter of time.  Glad they are generating revenue now.